Document is current
Any future updates will be listed below
-
Authors
Weintraub, Michael A.
Liu, Dazhi
DeMatteo, Raymond
Goncalves, Marcus DaSilva
Flory, James H. https://orcid.org/0000-0002-0259-969X
-
Funding
Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 11 June 2023
Accepted: 23 August 2023
First Online: 13 September 2023
Declarations
:
: M.A.W.: None to report. D.L., R.D.: None to report. M.D.G.: Received consulting fees from Novartis, Pfizer, and Scorpion Therapeutics; he is an inventor on a patent (pending) for Combination Therapy for PI3K-associated Disease or Disorder; and he is a co-founder, shareholder, and consultant of Faeth Therapeutics. J.F.: Hagens Berman Sobol Shapiro LLP (provision of services). J.H.F: None to report.
